Health CanadaGeneral Alert
AVASTIN (bevacizumab) – Higher Incidence of New Cases of Ovarian Failure Observe...
Published: November 14, 2011Recall ID: 24354Category: generalCountry: Canada
Product Description & Identification
AVASTIN (bevacizumab) – Higher Incidence of New Cases of Ovarian Failure Observed in Premenopausal Women – For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24354 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/avastin-bevacizumab-higher-incidence-new-cases-ovarian-failure-observed-premenopausal |
| Title | AVASTIN (bevacizumab) – Higher Incidence of New Cases of Ovarian Failure Observed in Premenopausal Women – For the Public |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2011-11-14 |
| Organization | Marketed health products |